Skip to main content
SpringerLink
Log in

The role of delay in stage III testicular tumours

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Twenty-nine patients with stage III testicular tumours seen between 1979 and 1984 were analysed for the relation between delay in both diagnosis and chemotherapy, and prognosis. The complete response (CR) rate was 40% for patients who were treated within 6 months from onset of symptoms, and 26.3% for patients who had an interval longer than 6 months.

We believe that delay in diagnosis and chemotherapy may affect the response to treatment. Health education of the male population for self-examination of the testes is an important factor to minimize this delay.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fraley, E. E., Lange, P. H., Kennedy, B. J.: Germ cell testicular cancer in adults.N. Eng. J. Med., 301, 1370 (1977).

    Google Scholar 

  2. Silvay, O., Yagoda, A., Wittes, R., Whitmore, W. F., Jr., Golbey, R.: Treatment of germ cell carcinomas with a combination of Actinomycin D, Vinblastine, and Bleomycin.Proc. Am. Assoc. Cancer Res., 14, 68 (1973).

    Google Scholar 

  3. Einhorn, L. H., Donohue, J. P.: Cis-diamminechloroplatinum, Vinblastine and Bleomycin combination chemotherapy in disseminated testicular cancer.Ann. Intern. Med., 87, 293 (1977).

    PubMed  Google Scholar 

  4. Golbey, R. B., Reynolds, T. F., Vugrin, D.: Chemotherapy of metastatic germ cell tumors.Semin. Oncol., 6, 82 (1979).

    PubMed  Google Scholar 

  5. Bosl, G. J., Lange, P. H., Kennedy, B. J.: Vinblastine, Bleomycin and Cis-diamminedichloroplatinum in the treatment of advanced testicular carcinoma.Am. J. Med., 68, 492 (1980).

    PubMed  Google Scholar 

  6. Scher, H., Bosl, G., Geller, N., Cirrincione, C., Whitmore, W., Golbey, R.: Impact of symptomatic interval on prognosis of patients with stage III testicular cancer.Urology, 21, 559 (1983).

    PubMed  Google Scholar 

  7. Bosl, G. J., Goldman, A., Lange, P. H., Vogelzang, N. J., Fraley, E. E., Levitt, S. H.: Impact of delay in diagnosis on clinical stage of testicular cancer.Lancet, 2, 970 (1981).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Hacettepe University School of Medicine, Ankara, Turkey

    A. Akdas, Z. Kirkali & D. Remzi

Authors
  1. A. Akdas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z. Kirkali
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Remzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akdas, A., Kirkali, Z. & Remzi, D. The role of delay in stage III testicular tumours. International Urology and Nephrology 18, 181–184 (1986). https://doi.org/10.1007/BF02082606

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02082606

Keywords

Search

Navigation